Category: Equity: Sectoral-Pharma and Healthcare |
Launch Date: 04-10-2023 |
Asset Class: Equity |
Benchmark: S&P BSE Healthcare |
TER: 2.35% As on (31-03-2024) |
Status: Open Ended Schemes |
Minimum Investment: 100.0 |
Minimum Topup: 100.0 |
Total Assets: 800.65 Cr As on (31-03-2024) |
Turn over: - | Exit Load: Exit load of 1%, if redeemed within 30 days. |
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
Standard Deviation | - |
Sharpe Ratio | - |
Alpha | - |
Beta | - |
Yield to Maturity | - |
Average Maturity | - |
Small Cap
38.21%
Others
2.53%
Large Cap
28.09%
Mid Cap
31.17%